Ohio Hemp THC Regulations: Complete Guide to State Laws and Compliance

Executive Summary

A federal court has temporarily blocked Ohio's new hemp-derived THC regulations, delivering a significant victory to beverage manufacturers and hemp retailers across the state. The August 2026 injunction halts enforcement of restrictions that would have severely limited the sale of intoxicating hemp products, including popular THC-infused drinks, seltzers, and edibles. The regulations, which Ohio officials attempted to implement through emergency rulemaking, sought to cap THC content in hemp products and impose strict licensing requirements on retailers. The court's decision preserves the status quo while litigation proceeds, allowing the state's burgeoning hemp beverage industry to continue operations. This case represents the latest flashpoint in a nationwide conflict between state regulators attempting to control intoxicating hemp products and an industry that emerged from the 2018 Farm Bill's hemp legalization.

The Ohio dispute centers on products containing delta-8 THC, delta-9 THC, and other hemp-derived cannabinoids that produce psychoactive effects similar to traditional marijuana. These products have proliferated in gas stations, convenience stores, and specialty retailers across Ohio since 2018, operating in a regulatory gray area. The blocked regulations would have required all hemp retailers to obtain state licenses, limited THC content to 0.3% by weight in finished products, and banned certain product formats entirely. Industry attorneys argued the rules exceeded the state's authority under the 2018 Farm Bill and would destroy thousands of jobs. The temporary injunction keeps these products on shelves while courts determine whether Ohio's regulatory approach conflicts with federal hemp law.

Why This Matters

Ohio's hemp THC regulatory battle affects a multi-million dollar industry, thousands of retail locations, and the competitive landscape between licensed marijuana operators and unregulated hemp sellers. The state's hemp beverage sector alone generates an estimated $150 million annually, according to industry trade groups. More than 3,000 retail locations across Ohio sell hemp-derived THC products, from dedicated vape shops to major convenience store chains. The regulatory uncertainty impacts manufacturers, distributors, retailers, and consumers who have come to rely on legal access to these products.

The stakes extend beyond economics. Ohio voters approved adult-use marijuana legalization in November 2023, creating a licensed and taxed cannabis market that began sales in 2024. Licensed marijuana dispensaries operate under strict regulations, pay substantial taxes, and face significant barriers to entry. Meanwhile, hemp-derived THC products—chemically similar or identical to marijuana—sell in unlicensed retail settings with minimal oversight. This parallel market creates competitive tension and regulatory confusion.

For consumers, the regulatory limbo raises safety concerns. Hemp-derived THC products lack the testing requirements, potency limits, and quality controls that apply to licensed marijuana products in Ohio. Public health officials have documented cases of mislabeled products, contamination, and unexpectedly high THC concentrations. Parents and educators worry about youth access, as hemp products appear in mainstream retail locations without age verification systems comparable to licensed dispensaries.

The Ohio case also serves as a bellwether for similar conflicts nationwide. At least 15 states attempted to regulate or ban intoxicating hemp products in 2025 and 2026, with varying degrees of success. Court decisions in Ohio will influence regulatory strategies in other states navigating the same federal-state tensions. The hemp industry watches closely, as adverse rulings could trigger a wave of state-level restrictions. Conversely, marijuana industry advocates monitor the case, hoping for regulatory clarity that levels the competitive playing field.

Background and History

Ohio's hemp THC controversy traces directly to the 2018 Farm Bill, which federally legalized hemp while creating an unintended loophole for intoxicating products. Understanding the current regulatory battle requires examining the evolution of hemp law, the emergence of delta-8 THC and similar cannabinoids, and Ohio's specific legislative and regulatory responses.

The 2018 Farm Bill and Hemp Legalization

On December 20, 2018, President Donald Trump signed the Agriculture Improvement Act of 2018, commonly known as the 2018 Farm Bill. Section 10113 removed hemp from Schedule I of the Controlled Substances Act, defining hemp as cannabis containing no more than 0.3% delta-9 THC on a dry weight basis. This definition applied to the plant itself, not to finished products derived from hemp. The distinction would prove critical.

The 2018 Farm Bill authorized states to submit regulatory plans to the U.S. Department of Agriculture for hemp cultivation programs. Ohio submitted its plan in 2019, and the USDA approved it in January 2020. The Ohio Department of Agriculture began licensing hemp farmers and processors under rules focused on agricultural production, not retail sales of finished consumer products. By 2021, Ohio had licensed more than 1,000 hemp cultivators and processors.

Emergence of Delta-8 THC and Intoxicating Hemp Products

In 2019 and 2020, manufacturers discovered they could convert CBD—abundant in legal hemp—into delta-8 THC through chemical processes. Delta-8 THC is a naturally occurring cannabinoid in cannabis, but only in trace amounts. The synthetic conversion process allowed mass production. Delta-8 produces psychoactive effects similar to delta-9 THC, the primary intoxicant in marijuana, though users typically report milder effects.

Products containing delta-8 THC, along with delta-10 THC, THC-O, HHC, and other semi-synthetic cannabinoids, flooded the market in 2020 and 2021. Manufacturers argued these products were legal under the 2018 Farm Bill because they derived from legal hemp, even though the finished products were intoxicating. The products appeared in vape cartridges, gummies, beverages, and other formats, sold through convenience stores, gas stations, and online retailers.

Ohio saw explosive growth in hemp-derived THC retail from 2020 through 2023. Major convenience store chains began carrying delta-8 products. Dedicated hemp retailers opened in strip malls across the state. By 2023, industry estimates suggested more than 2,500 retail locations in Ohio sold intoxicating hemp products, generating more than $100 million in annual sales.

Ohio's Medical and Adult-Use Marijuana Programs

Ohio legalized medical marijuana in 2016 through House Bill 523, signed by Governor John Kasich. The Ohio Medical Marijuana Control Program launched patient sales in January 2019, overseen by the State Board of Pharmacy and the Department of Commerce. The program required licensed cultivators, processors, testing laboratories, and dispensaries. Patients paid substantial costs for registry cards and products, and the state collected taxes and fees.

On November 7, 2023, Ohio voters approved Issue 2, legalizing adult-use marijuana for individuals 21 and older. The measure, which took effect December 7, 2023, allowed possession of up to 2.5 ounces and home cultivation of up to six plants per individual (12 per household). The Division of Cannabis Control, within the Department of Commerce, began accepting adult-use dispensary applications in 2024. Adult-use sales commenced in August 2024.

The licensed marijuana industry immediately faced competition from unregulated hemp products. Dispensaries paid hundreds of thousands of dollars for licenses, submitted to rigorous testing requirements, and collected a 10% excise tax on sales. Hemp retailers operated with no licensing, minimal testing, and no cannabis-specific taxation. Industry groups representing licensed marijuana operators began lobbying for hemp regulation.

Initial Legislative Attempts to Regulate Hemp

In 2023, Ohio legislators introduced multiple bills addressing intoxicating hemp products. House Bill 210, introduced in May 2023, proposed to regulate hemp-derived THC products similarly to adult-use marijuana, requiring state licensing for retailers and imposing potency limits. The bill stalled in committee amid opposition from hemp industry lobbyists and concerns about federal preemption.

Senate Bill 326, introduced in November 2023, took a different approach, seeking to ban synthetic cannabinoids like delta-8 THC while allowing naturally occurring hemp cannabinoids. This bill also failed to advance, caught between competing industry interests and uncertainty about the legal definition of "synthetic" under federal hemp law.

Throughout 2024, the Ohio General Assembly debated various regulatory frameworks. Licensed marijuana operators pushed for strict limits or outright bans on intoxicating hemp products. Hemp industry representatives argued for minimal regulation, citing the 2018 Farm Bill's preemption of state restrictions on hemp commerce. Consumer advocates called for safety testing and age restrictions. The legislative impasse continued into 2025.

Emergency Rulemaking and the 2026 Regulations

Frustrated by legislative inaction, the Ohio Department of Commerce and the State Board of Pharmacy initiated emergency rulemaking in early 2026. On March 15, 2026, the agencies published proposed rules that would classify intoxicating hemp products as "adult-use cannabis" subject to the same regulatory framework as marijuana. The rules proposed to require all hemp retailers to obtain state cannabis licenses, limit THC content in hemp products to 0.3% by weight in finished form, mandate laboratory testing, and restrict sales to individuals 21 and older.

The agencies justified the emergency rules under Ohio Revised Code Section 119.03, which allows expedited rulemaking to address immediate threats to public health and safety. Officials cited reports of youth access to intoxicating hemp products, cases of product contamination, and consumer complaints about mislabeling. The emergency rules were scheduled to take effect June 1, 2026, with a 90-day comment period.

The hemp industry immediately mobilized opposition. The Ohio Hemp Industry Association, representing manufacturers and retailers, retained legal counsel and prepared litigation. Individual companies, particularly beverage manufacturers who had invested millions in production facilities and distribution networks, coordinated their response. On May 20, 2026, a coalition of hemp beverage companies and retailers filed suit in the U.S. District Court for the Southern District of Ohio, challenging the regulations on multiple grounds.

The Federal Court Challenge

The complaint, filed by attorneys representing hemp beverage manufacturers and retail associations, argued that Ohio's emergency regulations violated the 2018 Farm Bill's provisions protecting interstate hemp commerce. Plaintiffs contended that 7 U.S.C. § 1639o prohibits states from restricting the transportation or shipment of hemp produced lawfully under the 2018 Farm Bill. They further argued the regulations exceeded the state's authority by redefining "hemp" in a manner inconsistent with federal law.

Plaintiffs also raised procedural challenges, arguing the emergency rulemaking process violated Ohio's Administrative Procedure Act by failing to demonstrate an immediate threat justifying expedited procedures. They presented evidence that intoxicating hemp products had been sold in Ohio for more than five years without documented public health crises, undermining the "emergency" justification.

On May 28, 2026, plaintiffs filed a motion for a temporary restraining order and preliminary injunction, seeking to block the June 1 effective date. Judge Sarah Morrison scheduled an expedited hearing for May 30. At the hearing, hemp industry attorneys presented testimony from beverage manufacturers describing investments in Ohio production facilities, employment figures, and distribution contracts that would be terminated if the regulations took effect. State attorneys defended the regulations as necessary consumer protection measures within Ohio's police powers.

Judge Morrison issued a temporary restraining order on May 31, 2026, one day before the regulations' scheduled effective date. The order maintained the status quo pending a full hearing on the preliminary injunction motion. On August 7, 2026, following additional briefing and oral arguments, Judge Morrison issued a preliminary injunction blocking enforcement of the regulations while the case proceeds to trial. The court found plaintiffs demonstrated a likelihood of success on their federal preemption claims and would suffer irreparable harm if the regulations took effect.

Key Players

The Ohio hemp THC regulatory battle involves state agencies, industry associations, individual companies, consumer advocates, and competing cannabis industry factions. Understanding each stakeholder's position and interests clarifies the complex dynamics driving the conflict.

Ohio Department of Commerce and Division of Cannabis Control

The Ohio Department of Commerce oversees the state's cannabis programs through its Division of Cannabis Control. The division administers licensing for marijuana cultivators, processors, dispensaries, and testing laboratories. Director James Canepa has publicly stated that intoxicating hemp products undermine the regulated marijuana market and pose consumer safety risks. The department initiated the emergency rulemaking process and defends the regulations in federal court. The division's position reflects concerns about regulatory arbitrage, where similar products face vastly different oversight depending on their nominal source (hemp versus marijuana).

Ohio State Board of Pharmacy

The State Board of Pharmacy regulates Ohio's medical marijuana program and pharmacy practice generally. The board joined the Department of Commerce in promulgating the hemp regulations, citing its authority over controlled substances and consumer protection. Board President Shawn Wilt has emphasized safety concerns, particularly regarding product testing and labeling accuracy. The board's involvement reflects its traditional role in pharmaceutical regulation and its interest in ensuring cannabis products meet quality standards.

Ohio Hemp Industry Association

The Ohio Hemp Industry Association represents hemp farmers, processors, manufacturers, and retailers. The association formed in 2019 following the 2018 Farm Bill's passage and has grown to include more than 300 member companies. Executive Director Jennifer Hayes has been the public face of opposition to the regulations, arguing they would destroy a legitimate agricultural industry and thousands of jobs. The association coordinated the legal challenge and funded initial litigation costs through member assessments.

Hemp Beverage Manufacturers

Several Ohio-based beverage companies emerged as lead plaintiffs in the federal lawsuit. These companies invested in production facilities, developed proprietary formulations, and established distribution networks for THC-infused seltzers, teas, and other drinks. Companies like Great Lakes Hemp Beverages and Buckeye Botanical Drinks employ dozens of workers and distribute products to hundreds of retail locations. The beverage sector represents the fastest-growing segment of Ohio's hemp market, with sales increasing 300% from 2024 to 2025 according to industry data.

Ohio Cannabis Coalition

The Ohio Cannabis Coalition represents licensed marijuana dispensaries, cultivators, and processors. The coalition supported the hemp regulations, arguing that unregulated hemp products create unfair competition and consumer confusion. Coalition spokesperson Michael Torres has emphasized the disparity in regulatory burdens, noting that licensed operators invest millions in compliance while hemp retailers face no comparable requirements. The coalition represents the economic interests of the regulated marijuana industry, which views intoxicating hemp products as direct competitors selling similar products without equivalent costs or restrictions.

Consumer and Public Health Advocates

Organizations like the Ohio Public Health Association and Safe Cannabis Ohio have called for hemp product regulation focused on safety testing, labeling accuracy, and youth access prevention. These groups generally support regulatory oversight but have expressed concerns about overly restrictive approaches that might drive consumers to unregulated black markets. Dr. Rachel Kim, representing the Ohio Public Health Association, has advocated for evidence-based regulations that balance access for adult consumers with protection for minors and vulnerable populations.

Legal and Regulatory Framework

The Ohio hemp THC dispute sits at the intersection of federal hemp law, state cannabis regulations, and constitutional principles of federalism and preemption. Multiple legal frameworks govern the production, distribution, and sale of hemp-derived cannabinoid products.

Federal Law: The 2018 Farm Bill

The Agriculture Improvement Act of 2018, codified at 7 U.S.C. § 1639o et seq., defines hemp as "the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis." This definition removed hemp from the Controlled Substances Act's Schedule I classification.

Section 1639p of Title 7 prohibits states from restricting the interstate transportation or shipment of hemp lawfully produced under the 2018 Farm Bill. This provision forms the basis for hemp industry preemption arguments against state regulations. However, the statute does not explicitly address state authority to regulate finished hemp products sold to consumers within state borders.

The 2018 Farm Bill preserved FDA authority over hemp-derived products marketed as foods, dietary supplements, or drugs. The FDA has issued warning letters to companies making therapeutic claims about CBD products but has not established comprehensive regulations for hemp-derived cannabinoids in consumer products. This regulatory gap created the market opportunity for intoxicating hemp products.

The Controlled Substances Act and DEA Interpretation

The Controlled Substances Act, 21 U.S.C. § 812, classifies marijuana as a Schedule I controlled substance. Following the 2018 Farm Bill, the DEA published an interim final rule in August 2020 conforming its regulations to hemp's legal status. However, the DEA stated that "all synthetically derived tetrahydrocannabinols remain schedule I controlled substances," creating ambiguity about the legal status of delta-8 THC and similar cannabinoids produced through chemical conversion of CBD.

The DEA has not issued definitive guidance on whether delta-8 THC derived from hemp through isomerization constitutes a "synthetically derived" cannabinoid under the Controlled Substances Act. This regulatory uncertainty has allowed the intoxicating hemp market to flourish while leaving manufacturers and retailers vulnerable to potential federal enforcement.

Ohio Revised Code and Cannabis Statutes

Ohio Revised Code Chapter 3796 governs the state's medical marijuana program, establishing licensing requirements, testing standards, and operational regulations for cultivators, processors, and dispensaries. Chapter 3780, enacted following the passage of Issue 2 in 2023, creates the regulatory framework for adult-use cannabis, including possession limits, licensing procedures, and taxation.

Ohio Revised Code Section 928.01 defines hemp consistent with the 2018 Farm Bill and authorizes the Department of Agriculture to regulate hemp cultivation. However, the statute does not explicitly address the manufacture and retail sale of finished hemp products containing intoxicating cannabinoids. This statutory gap created the opening for the Department of Commerce's emergency rulemaking attempt.

The Challenged Emergency Regulations

The March 2026 emergency regulations proposed by the Ohio Department of Commerce would have amended Ohio Administrative Code Chapter 3796 to include hemp-derived intoxicating products within the definition of "adult-use cannabis." Key provisions included requiring all retailers of intoxicating hemp products to obtain state cannabis retail licenses, limiting THC content in finished hemp products to 0.3% by total weight, mandating laboratory testing for potency and contaminants, and restricting sales to individuals 21 and older with government-issued identification.

The regulations defined "intoxicating hemp product" as any hemp-derived product containing more than 0.3% total THC by weight, including delta-8 THC, delta-10 THC, THC-O, HHC, and other cannabinoids with psychoactive properties. This definition would have effectively banned most existing hemp beverage and edible products, which typically contain 5-10 mg of THC per serving but constitute less than 0.3% THC by total product weight.

Federal Preemption Doctrine

The Supremacy Clause of the U.S. Constitution, Article VI, Clause 2, establishes that federal law preempts conflicting state law. Federal preemption can be express (explicitly stated in federal statute), field preemption (federal regulation is so comprehensive that it occupies the entire regulatory field), or conflict preemption (state law conflicts with federal law or frustrates federal objectives).

Hemp industry attorneys argue the 2018 Farm Bill expressly preempts state restrictions on hemp commerce through 7 U.S.C. § 1639p. They contend Ohio's regulations conflict with federal law by effectively prohibiting products that meet the federal definition of hemp. State attorneys counter that the 2018 Farm Bill preserves state police powers to regulate products sold within state borders for consumer protection purposes, and that the statute only preempts restrictions on interstate transportation of hemp, not intrastate retail sales.

Market and Business Implications

The regulatory uncertainty surrounding Ohio hemp THC products creates significant business risks and opportunities across the cannabis supply chain. The outcome of the litigation will determine the viability of a multi-million dollar industry and reshape competitive dynamics between licensed marijuana operators and hemp retailers.

The Ohio hemp-derived THC market generated an estimated $180 million in retail sales in 2025, according to industry analysts. Beverage products accounted for approximately $150 million of that total, with gummies, vapes, and other formats comprising the remainder. More than 3,000 retail locations carried hemp THC products as of early 2026, including major convenience store chains like Speedway and GetGo, independent vape shops, and dedicated hemp retailers.

If the preliminary injunction is lifted and Ohio's regulations take effect, industry analysts project that 80-90% of current hemp retailers would be unable to obtain cannabis retail licenses due to location restrictions, capital requirements, and limited license availability. The Division of Cannabis Control has issued fewer than 200 adult-use retail licenses statewide as of August 2026, and many jurisdictions prohibit cannabis retailers through local zoning ordinances. The effective elimination of most retail outlets would devastate hemp beverage manufacturers who built distribution networks around convenience store and gas station sales.

Manufacturing operations face similar risks. Companies like Great Lakes Hemp Beverages invested more than $5 million in production facilities, canning lines, and quality control systems. These facilities employ 50-100 workers in manufacturing, distribution, and administrative roles. If regulations force these companies out of the Ohio market, the investments become stranded assets with limited alternative uses. Some manufacturers have explored pivoting to non-intoxicating CBD beverages, but market research suggests demand for CBD drinks is a fraction of THC beverage sales.

For licensed marijuana operators, the regulatory battle presents both opportunities and challenges. Dispensaries would benefit from reduced competition if hemp THC products are restricted or banned. However, some multi-state operators have hedged their positions by investing in hemp beverage companies or developing their own hemp product lines. These operators face internal conflicts between their licensed marijuana divisions, which benefit from restricting hemp competition, and their hemp divisions, which profit from the current regulatory arbitrage.

The taxation implications are substantial. Ohio's 10% adult-use cannabis excise tax generated more than $100 million in revenue in the first year of legal sales. Hemp products, sold through unlicensed retailers, generate no cannabis-specific tax revenue beyond standard sales tax. If hemp products were brought into the licensed system, the state could collect an additional $15-20 million annually in excise taxes, according to Department of Commerce estimates. However, industry analysts question whether consumers would continue purchasing hemp products at the higher post-tax prices, or would instead shift to licensed marijuana products or illicit market alternatives.

Investment capital has largely withdrawn from the Ohio hemp sector pending regulatory clarity. Venture capital firms and private equity investors who funded hemp beverage startups in 2023 and 2024 have paused additional investments. Several planned production facility expansions were cancelled in 2025 and 2026 due to regulatory uncertainty. Conversely, licensed marijuana operators have attracted increased investment, as investors view regulatory restrictions on hemp competition as reducing market risk for licensed businesses.

What Experts Say

Legal scholars, industry analysts, and public health experts offer divergent perspectives on Ohio's hemp regulation controversy, reflecting broader debates about cannabis federalism and consumer protection. The expert commentary reveals fundamental disagreements about the scope of state regulatory authority under the 2018 Farm Bill and the appropriate balance between market access and public safety.

Professor Douglas Berman of Ohio State University's Moritz College of Law, a nationally recognized expert on drug policy and federalism, has written extensively on the hemp regulation conflict. According to Berman's analysis published in the Ohio State Law Journal, the 2018 Farm Bill's preemption language is ambiguous regarding state authority over intrastate hemp product sales. Berman argues that while the statute clearly prohibits states from restricting interstate hemp transportation, it does not explicitly prevent states from regulating retail sales of finished products to consumers within state borders. He suggests courts will likely apply traditional federalism principles that presume states retain police powers to regulate for health and safety unless Congress clearly intended to preempt such authority.

Cannabis industry attorney Hilary Bricken, who practices in multiple states and advises hemp and marijuana clients, has stated that Ohio's emergency regulations likely exceed state authority under the 2018 Farm Bill. In a legal analysis published on her firm's cannabis law blog, Bricken contends that requiring hemp retailers to obtain marijuana licenses effectively prohibits hemp commerce by imposing requirements that most hemp businesses cannot meet. She argues this functional prohibition conflicts with the 2018 Farm Bill's intent to create a legal hemp industry and violates the statute's restrictions on state interference with hemp markets.

Dr. Steven Hoffman, a public health researcher at Ohio State University's College of Public Health, has published studies on intoxicating hemp product safety and consumer knowledge. According to Hoffman's research, published in the Journal of Cannabis Research, laboratory testing of hemp-derived THC products purchased from Ohio retailers found significant discrepancies between labeled and actual THC content in 35% of samples. Hoffman's work documents cases of products containing two to three times the labeled THC concentration, raising concerns about unintentional overconsumption and impaired driving. His research supports regulatory interventions focused on testing and labeling accuracy, though he has not taken a position on whether outright bans or license requirements are appropriate policy responses.

Industry analyst John Kagia, chief knowledge officer at New Frontier Data, a cannabis market research firm, has tracked the economic impact of intoxicating hemp products on licensed marijuana markets nationwide. According to Kagia's analysis, states with unrestricted hemp THC markets have seen 15-20% lower sales growth in licensed marijuana dispensaries compared to states that banned or heavily regulated hemp products. Kagia's data suggests significant consumer substitution between hemp and marijuana products, supporting licensed industry arguments that hemp competition undermines regulated markets. However, he notes that restricting hemp products does not guarantee increased marijuana sales, as some consumers may exit legal markets entirely rather than pay higher dispensary prices.

Attorney Shane Pennington, a partner at Vicente LLP who represents hemp industry clients nationally, has argued that state attempts to regulate intoxicating hemp products are legally vulnerable under the 2018 Farm Bill. In testimony before state legislatures and in legal briefs, Pennington has contended that the federal statute's definition of hemp includes all derivatives and extracts from compliant hemp plants, regardless of intoxicating properties. He argues that states cannot redefine hemp based on finished product characteristics without conflicting with federal law. Pennington's position represents the hemp industry's core legal theory in challenges to state regulations.

Consumer advocate Larisa Bolivar, executive director of the Cannabis Consumers Coalition, has called for regulatory approaches that protect consumer safety without eliminating market access. According to Bolivar's statements in public forums, regulations should focus on testing, labeling, age restrictions, and retailer education rather than outright bans or prohibitive licensing requirements. She argues that overly restrictive regulations drive consumers to unregulated black markets where products lack any safety oversight, creating greater public health risks than the regulated hemp market poses.

What's Next

The Ohio hemp THC regulatory battle will unfold through multiple legal, legislative, and administrative proceedings over the next 12-24 months. Several key decision points and deadlines will shape the industry's future and determine whether intoxicating hemp products remain available in Ohio.

The federal court litigation proceeds toward trial on the merits of the hemp industry's challenge to Ohio's regulations. Judge Morrison's August 2026 preliminary injunction preserves the status quo but does not resolve the underlying legal questions. The state has until September 15, 2026, to file its answer to the complaint and any counterclaims. Discovery will likely extend through early 2027, with depositions of state officials, industry representatives, and expert witnesses. Trial is tentatively scheduled for June 2027, though the court may issue summary judgment rulings on key legal issues before trial if the parties file appropriate motions.

The preliminary injunction remains in effect until the court issues a final judgment or modifies the injunction based on changed circumstances. The state could seek to dissolve the injunction by demonstrating immediate public health threats that justify emergency restrictions, but such a motion would require substantial evidence of concrete harms. The hemp industry will resist any attempt to lift the injunction, arguing that allowing the regulations to take effect would cause irreparable business harm even if the industry ultimately prevails at trial.

Parallel to the federal litigation, the Ohio General Assembly may attempt legislative solutions. Several bills addressing hemp regulation are pending in committee as of August 2026. House Bill 445, introduced in July 2026, would establish a separate licensing system for hemp retailers with lower fees and fewer restrictions than marijuana licenses. The bill would impose testing requirements, age restrictions, and labeling standards but would not cap THC content in finished products. Senate Bill 389 takes a more restrictive approach, proposing to ban all intoxicating hemp products except those sold through licensed marijuana dispensaries.

Legislative action faces significant obstacles. The hemp industry has mobilized substantial lobbying resources to oppose restrictive bills, while the licensed marijuana industry pushes for strict limits or bans. Republican legislative leaders have expressed reluctance to expand state regulation of commerce, while some Democrats support consumer protection measures. The divided political landscape makes comprehensive legislation difficult to pass, particularly in an election year. Most observers expect the legislature to defer action pending the federal court's resolution of the legal questions.

The FDA's potential regulatory action represents another variable. The agency has authority to regulate hemp-derived cannabinoids in food and beverage products but has not issued comprehensive rules. In May 2026, the FDA announced it would seek public comment on a proposed framework for hemp-derived CBD in foods and dietary supplements, but the proposal did not address intoxicating cannabinoids like delta-8 THC. If the FDA issues regulations prohibiting or restricting intoxicating hemp products, state regulatory efforts would have clearer federal support. However, FDA rulemaking typically takes years, and the agency has shown limited appetite for aggressive hemp enforcement.

Industry participants are preparing for multiple scenarios. Hemp beverage manufacturers are diversifying into other states and developing non-intoxicating product lines as hedges against adverse Ohio outcomes. Some companies are exploring partnerships with licensed marijuana operators to position themselves for potential integration into the regulated system. Licensed dispensaries are monitoring the litigation and preparing to expand product offerings if hemp competition is restricted. Retailers are stockpiling inventory and negotiating contract terms that allow them to return unsold products if regulations change.

Consumer behavior will ultimately determine market outcomes regardless of regulatory developments. If Ohio successfully restricts hemp products, analysts will watch closely to see whether consumers shift to licensed marijuana dispensaries, reduce consumption, or seek products through illicit channels. The data will inform regulatory debates in other states facing similar decisions. Conversely, if hemp products remain available, the impact on licensed marijuana sales will shape industry arguments about the need for competitive restrictions.

Further Reading

• Agriculture Improvement Act of 2018 (2018 Farm Bill), Public Law 115-334, 7 U.S.C. § 1639o et seq. — https://www.congress.gov/bill/115th-congress/house-bill/2
• Ohio Revised Code Chapter 3796 (Medical Marijuana Control Program) — https://codes.ohio.gov/ohio-revised-code/chapter-3796
• Ohio Revised Code Chapter 3780 (Adult Use Cannabis) — https://codes.ohio.gov/ohio-revised-code/chapter-3780
• Ohio Department of Commerce, Division of Cannabis Control — https://cannabis.ohio.gov
• DEA Interim Final Rule on Hemp (August 2020), 85 Fed. Reg. 51639 — https://www.federalregister.gov/documents/2020/08/21/2020-18484/implementation-of-the-agriculture-improvement-act-of-2018
• Ohio State University Moritz College of Law, Drug Enforcement and Policy Center — https://moritzlaw.osu.edu/depc
• New Frontier Data, Cannabis Market Research and Analysis — https://newfrontierdata.com
• Ohio Hemp Industry Association — https://ohiohempassociation.org
• U.S. District Court for the Southern District of Ohio case docket (case number to be confirmed upon filing) — https://www.ohsd.uscourts.gov